California 2025-2026 Regular Session

California Assembly Bill AB2011

Introduced
2/17/26  
Refer
3/2/26  
Report Pass
3/25/26  
Refer
3/25/26  
Report Pass
4/8/26  
Engrossed
4/27/26  

Caption

Nonquantitative treatment limitations.

Impact

AB 2011 is poised to strengthen the existing framework set by the federal Mental Health Parity and Addiction Equity Act of 2008 (MHPAEA) and California's earlier state legislation mandating equal treatment for mental health conditions. By mandating health plans to document and evaluate data regarding their NQTLs, the bill aims to clarify compliance with parity laws, potentially leading to improved access for individuals seeking mental health and substance use disorder treatment. The bill requires that health service plans conduct and submit comparative analyses annually, ensuring oversight and accountability for compliance with parity standards.

Summary

Assembly Bill 2011, introduced by Assembly Member Hart and coauthored by Senator Wiener, aims to address disparities in healthcare coverage for mental health and substance use disorder treatments compared to general medical services. The bill seeks to prohibit health care service plans and insurers from employing discriminatory factors when establishing nonquantitative treatment limitations (NQTLs) on mental health and substance use disorder benefits. This legislative initiative is grounded in the belief that existing practices do not ensure equitable treatment for these conditions, contributing to delayed access to necessary care for many individuals.

Conclusion

Overall, AB 2011 embodies a significant legislative effort to reform mental health healthcare coverage, fostering an expectation of compliance with established parity laws. The requirement for thorough comparative analyses and the potential consequences for noncompliance underscore the commitment to nondiscriminatory practices in health insurance coverage. It could serve as a critical advancement in protecting the rights of individuals with mental health and substance abuse disorders, ensuring they receive treatment comparable to that of physical health conditions.

Contention

While supporters tout the bill as a necessary step toward equitable healthcare, opponents may contend that imposing stringent requirements on insurers could increase operational costs. There may be concerns about the feasibility of compliance, with potential arguments regarding the burden on insurance providers to fulfill the documentation and analytical requirements outlined in the bill. Furthermore, stakeholders may raise issues about how such changes could potentially lead to increased premiums or reduced provider networks, ultimately affecting accessibility despite the intention of improved parity.

Companion Bills

No companion bills found.

Previously Filed As

CA SB22

An Act To Amend Title 18 Of The Delaware Code Relating To Insurance Coverage.

CA HB07207

An Act Concerning The Disclosure Of Insurer Reports Concerning Treatment Limitations On Mental Health And Substance Use Disorder And Other Benefits As A Public Record.

CA AB2233

Behavioral health treatment plans.

CA AB1949

Medi-Cal: acupuncture treatments.

CA AB350

Health care coverage: fluoride treatments.

CA HB1424

To Mandate Coverage For Severe Obesity Treatments.

CA HB1002

Medical Necessity Determination Insurance Coverage

CA SB45

Medicaid Mental Health Parity

CA SB1720

Clozapine; access; treatment protocols

CA SB00010

An Act Concerning Health Insurance And Patient Protection.

Similar Bills

CA AB2657

Prescriptions.

CA AB1612

Disposition of controlled substances.

CA SB6

An act to amend Sections 11014.

FL H0567

Podiatric Medicine

CA AB384

Health care coverage: mental health and substance use disorders: inpatient admissions.

CA AB1778

Controlled substances: testosterone.

CA AB1785

California Uniform Controlled Substances Act: online retailer.

FL S0646

Drug Paraphernalia